Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "ferritin, light polypeptide pseudogene" (ENSG00000270282) is classified as a **pseudogene** related to the ferritin light chain gene (FTL), not as a protein-coding gene or functional therapeutic target[1][8]. Pseudogenes are segments of DNA that resemble functional genes but are generally non-functional due to mutations, truncations, or lack of regulatory elements needed for expression[1][4]. The functional, protein-encoding FTL gene is associated with iron storage and a range of biological and disease processes, but pseudogenes like ENSG00000270282 do not encode active proteins and are not recognized as receptors, enzymes, or drug targets. There are numerous related FTL pseudogenes, some of which may be transcribed, but ENSG00000270282 is not considered a therapeutic target and does not have defined drug interactions or mechanisms of action. Therefore, there is likely an issue with the target name provided: while "ferritin light chain" (FTL) is an important gene/protein, "ferritin, light polypeptide pseudogene" is not a molecular target in the conventional sense[1][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ferritin, light polypeptide pseudogene.